Volume 6, Supplement 1 (May 2000)Symposium: HIV and the Nervous System:
Emerging Issues
Current approaches to treatment for
HIV-1 infection
HIV-1 infected mononuclear phagocyte
secretory products affect neuronal physiology leading to cellular
demise: relevance for HIV-1-associated dementia
Chemokine receptors and mechanisms of
cell death in HIV neuropathogenesis
Neurologic disease in injection drug
users: therapeutic issues Neuronal apoptosis in human immunodeficiency virus
infection
Biphasic and regionally-restricted
chemokine expression in the central nervous system in the Theiler's
virus model of multiple sclerosis
Characterization of
cultured microglia that can be infected by HIV-1 Functional expression of
the seven-transmembrane HIV-1 co-receptor APJ in neural cells Analysis of human
immunodeficiency virus type 1 gp160 sequences from a patient with
HIV dementia: evidence for monocyte trafficking into brain Mechanisms of leukocyte trafficking
into the CNS
Persistent pathogens in
the parenchyma of the brain Stages of restricted HIV-1
infection in astrocyte cultures derived from human fetal brain
tissue Molecular analysis of
cerebrospinal fluid: potential for the study of HIV-1 infection of
the central nervous system Neuronal damage - recent issues and
implications for therapy HIV and the nervous
system: emerging issues. Washington DC, USA. April 14-16, 1999.
|